Looking for an opportunity to meet key management officers from Roche and learn more about the health and medtech industry? Join us for the ACE-Roche Digital Transformation Exchange this July 2019!

As the world's largest biotech company and one of the highest R&D spend in the world across all industries, Roche is a global leader in personalised healthcare, cancer treatments and in vitro diagnostics.

Roche Diagnostics is looking to meet ecosystem players and co-innovate with startups globally in the areas of

• Clinical Algorithms - digital solutions
• Test Interpretations - derive diagnostic insights
• Digital Biomarkers - connected digital tools to explain/predict
• Disease Management - identify, intervene, measure and improve
• Clinical Decision Support - suggest right action
• Point of Care Diagnostics - rapid and convenient
• Diagnostics Lab Quality Control - leveraging AI

This event will be attended by top global and regional management of Roche Diagnostics such as:

• Global Head of Centralized & Point of Care Solutions
• Global Head of Digital Health Innovation
• APAC Head of Business Development
• APAC Head of IT
• Executive Directors of digital innovation, marketing and various business units (Molecular Solutions, Clinical Decision Support, Customer Advocacy & Solutions)

This closed-door event is also open to biotech/medtech/healthtech related ecosystem players like VCs, accelerators, incubators and government agencies.

Priority for medtech startups that have demonstrated commercial success with existing products or MVP with customers.

For companies in the area of oncology/cardiology/acute care/infectious diseases and would like to share on upcoming trends and opportunities, please email your slide deck to ace.dte.medtech@gmail.com by 19 June. Note that this is not a pitching session but an info session. Only shortlisted companies will be notified.

Free ACE Startups membership worth up to $80k until Aug 2019. If you haven't signed up, please do so here: https://tinyurl.com/ACEstartups

Date: 8 July 2019, Mon

Time: 2.30 pm - 5.30 pm

Venue: ACE Ideation Centre (Blk 79)

Programme:

2.30pm: Registration

3.00pm: Welcome address by Mr Edmas Neo, CEO of ACE

3:05pm: Sharing on innovation festival by ACE

3:15pm: Sharing on problem statements by Roche Diagnostics

3:30pm: Sharing by selected startups + Q&A by audience

5:00pm: Photo-taking and closed-door networking

5.30pm: End

About Digital Transformation Exchange (DTE)

ACE organises a series of DTE events, where companies can discover upcoming trends and opportunities, embrace innovation and potentially adopt these solutions to scale up their business. This July, DTE will feature leading technology innovators in the Medical Tech sectors. You may find press releases on some of our past DTE sessions on HR Tech and Foodtech from The Business Times, Today and Lianhe Zaobao Online. Stay ahead on the digital front and accelerate your digital transformation journey with us!

Action Community for Entrepreneurship (ACE)

Action Community for Entrepreneurship (ACE) was launched in 2003 by the Ministry of Trade & Industry as a national effort to foster innovation and entrepreneurship in Singapore. It was restructured in 2014 as a private-led initiative supported by the government to continue its national mandate to drive entrepreneurship initiatives in Singapore. ACE supports startups across all stages and focuses on three strategic areas:

• Driving co-innovation between startups and enterprises
• Helping startups to scale and internationalise
• Building an access hub of connected ecosystems across countries

Roche
Roche is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. A pioneer in healthcare, Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Roche Diagnostics develops and integrates diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, Roche Diagnostics offers the industry’s most comprehensive in vitro diagnostics solutions, covering molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next-generation sequencing, and laboratory automation and IT, and decision support solutions.